India’s Cipla to make and sell Eli Lilly’s baricitinib to treat Covid-19, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab., The agreement comes at a time when India is struggling with a catastrophic second wave of the pandemic, leading to an acute shortage of coronavirus medicines such as remdesivir and tocilizumab., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *